ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Actemra 400 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung - Durchstechflasche(n)
58868003 Roche Pharma (Schweiz) AG
Actemra 400 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung02.12.2008
  02.12.2008
Tocilizumab (L04AC07) 
WHO-DDD 
07.15.Durchstechflasche(n)
07.15. 
A  
Yes 
IPCI
648.78Yes
    
10 %722.00
7680588680035Biotechnologika
4038181 
Composition
tocilizumabum 400 mg, polysorbatum 80, saccharum, dinatrii phosphas dodecahydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 8.84 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Tocilizumabum400mg / 20ml
BAG: Active AgentDose
Tocilizumabum400 mg
 
Inactive agents
Disodium Phosphate Dodecahydrate
Sodium Dihydrogenophosphate Dihydrate
Polysorbatum 80
Saccharum
 
Source
Data was imported : 08.06.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home